NHS Weight Loss Injections in England 2026: Wegovy, Mounjaro and Who Can Qualify

Eligibility depends on factors such as BMI, weight-related health conditions, the medicine being considered, and the local NHS pathway.

In England, Wegovy (semaglutide) and Mounjaro (tirzepatide) are among the medicines used within NHS weight management pathways for eligible people. Access is being introduced through specialist services and, for tirzepatide, through a phased primary-care rollout.

If you are searching for NHS weight loss injections, Wegovy on the NHS, Mounjaro on the NHS, NHS eligibility or weight loss injection costs, the key point is that there is no single rule that applies to everyone.

How Do NHS Weight Loss Injections Work?

Weight management medicines are prescription treatments used alongside lifestyle measures.

Some of the medicines used in NHS weight management include:

Tirzepatide, sold as Mounjaro Semaglutide, sold as Wegovy Liraglutide, sold as Saxenda Orlistat, which is taken as a capsule rather than an injection

NICE's current guidance recommends that medicines for weight management are used alongside a reduced-calorie diet and increased physical activity.

The exact medicine offered depends on the person's clinical circumstances, eligibility, local pathway and the healthcare professional's assessment.

Who Can Get Weight Loss Injections on the NHS?

There is no universal NHS rule saying that everyone above a particular BMI can receive a weight loss injection.

The eligibility criteria depend on the specific medicine and the NHS service providing treatment.

For example, NICE recommends semaglutide for certain adults with obesity who have at least one weight-related health condition and meet the relevant BMI and specialist-service criteria.

For tirzepatide, NICE recommends treatment for eligible adults with an initial BMI of at least 35 kg/m² and at least one weight-related health condition, with lower BMI thresholds generally used for certain ethnic groups. NHS England is implementing the treatment through a phased approach.

Possible weight-related health conditions can include:

Type 2 diabetes High blood pressure Cardiovascular disease Obstructive sleep apnoea Abnormal blood lipid levels Other conditions identified within the relevant clinical pathway

Meeting a BMI threshold alone does not automatically guarantee an NHS prescription.

What BMI Is Needed for NHS Weight Loss Injections?

BMI is an important part of eligibility, but it is not the only factor.

For semaglutide, NICE recommends NHS use in a specialist weight management service for adults with at least one weight-related comorbidity and either a BMI of 35 or above, or a BMI between 30 and 34.9 when the person meets the relevant criteria for referral to specialist services. Lower BMI thresholds, usually by 2.5 kg/m², apply for people from several ethnic backgrounds where obesity-related risks can occur at lower BMI levels.

For tirzepatide, NICE's recommendation is based on an initial BMI of at least 35 kg/m² plus at least one weight-related comorbidity, with the same general 2.5 kg/m² BMI adjustment for certain ethnic groups.

However, the practical NHS pathway can be more restrictive because services are being introduced and commissioned in stages.

This means someone who appears to meet a general BMI criterion may still need a specialist assessment before treatment is offered.

Wegovy on the NHS: Who May Qualify?

Wegovy contains semaglutide and is administered once a week.

NICE recommends semaglutide for weight management in certain adults as part of a specialist weight management service. Treatment is intended to be combined with a reduced-calorie diet and increased physical activity.

The NICE criteria include:

At least one weight-related health condition A BMI of at least 35 kg/m², or A BMI between 30 and 34.9 kg/m² when the person meets the relevant specialist-service referral criteria

Lower BMI thresholds generally apply for people from certain ethnic backgrounds.

Wegovy should therefore not be viewed as a routine NHS prescription available to anyone who wants to lose weight.

A specialist service needs to assess whether it is appropriate.

Mounjaro on the NHS: Who May Qualify?

Mounjaro contains tirzepatide and is another important medicine in the NHS weight management pathway.

NICE recommends tirzepatide for eligible adults with obesity who have at least one weight-related health condition. The initial BMI criterion is generally 35 kg/m² or higher, with lower thresholds used for certain ethnic groups.

NHS England is taking a phased approach to introducing tirzepatide into primary care.

Initially, access is focused on people with the highest clinical need. NHS England states that people accessing tirzepatide through primary care may be eligible if they have a BMI of 35 or more, adjusted for ethnicity, and have been diagnosed with four of the specified weight-related health conditions.

This is an important distinction.

The NICE recommendation and the current NHS England implementation pathway are related but should not be treated as exactly the same thing.

Local availability and referral arrangements can therefore affect access.

How Do You Access Weight Loss Injections Through the NHS?

The process usually starts with a healthcare professional assessing your health and weight-management needs.

Depending on the medicine and local pathway, this may involve:

Step 1: Initial assessment

Your GP or another healthcare professional may review your BMI, medical history, existing conditions and previous weight-management efforts.

Step 2: Referral

If appropriate, you may be referred to a specialist overweight and obesity management service.

Step 3: Specialist assessment

The specialist team can assess whether medication is suitable and which treatment options may be appropriate.

Step 4: Treatment and support

If medication is prescribed, it is generally combined with dietary, physical activity and behavioural support.

NICE specifically advises that people considering semaglutide or liraglutide should be referred to a specialist service for assessment, while tirzepatide can be prescribed in primary care or specialist services when the relevant criteria and NHS England implementation arrangements are met.

How Much Do NHS Weight Loss Injections Cost?

This is where it is important to distinguish NHS patient charges from the underlying medicine price.

In England, the standard NHS prescription charge is currently £9.90 per item for people who are required to pay. Some people qualify for free NHS prescriptions because of age, income, medical conditions or other exemptions.

The NHS does not simply charge patients the commercial list price of a weight loss medicine.

For example, NICE lists a commercial arrangement for semaglutide, meaning NHS organisations receive the medicine under an agreed discounted arrangement.

For tirzepatide, NICE lists commercial prices for a four-week supply ranging from £133 for the 2.5 mg dose to £330 for the 12.5 mg and 15 mg doses, excluding VAT. These are medicine list prices rather than the amount an eligible NHS patient necessarily pays. NHS access is subject to a separate commercial arrangement.

Therefore, searching for “Wegovy NHS cost” or “Mounjaro NHS cost” can produce very different figures depending on whether the source is discussing:

NHS prescription charges Medicine list prices Commercial NHS pricing Private clinic prices Private pharmacy prices

These should not be confused.

What About NHS Prescriptions Outside England?

The title “NHS weight loss injections UK” can be misleading because healthcare arrangements differ across the UK.

The £9.90 prescription charge applies to England. Prescriptions in Scotland, Wales and Northern Ireland have different charging arrangements, with NHS prescriptions generally free at the point of dispensing in those nations.

Therefore, if you are searching for:

NHS weight loss injections Scotland NHS weight loss injections Wales NHS weight loss injections Northern Ireland

you should check the relevant national health service rather than automatically applying NHS England criteria.

NHS vs Private Weight Loss Injections

People who do not qualify for NHS treatment, or who face delays in accessing services, may consider private weight management.

Private providers can offer assessment and prescribing services where clinically appropriate.

However, private treatment does not mean that everyone automatically qualifies.

A legitimate provider should still conduct an appropriate clinical assessment before prescribing a prescription-only medicine.

When comparing private services, check:

Whether a qualified prescriber reviews your medical information Whether the medicine is prescription-only and supplied through an appropriate pharmacy Whether follow-up monitoring is available What happens if side effects occur Whether the quoted price includes consultation and medication Whether ongoing prescriptions involve additional charges How the provider handles dose changes or treatment discontinuation

Private prices can vary substantially, so a low advertised starting price should not automatically be treated as the total monthly cost.

Are Online Weight Loss Injections Safe?

Buying prescription weight loss medicines online requires particular caution.

MHRA has warned about illegal weight-loss medicines sold through unregulated websites and social media. Products obtained through illegal channels may be fake, contaminated, incorrectly dosed or contain ingredients that are not listed on the packaging.

In 2026, MHRA also continued taking action against public advertising of prescription-only weight loss medicines and services where advertising could encourage members of the public to request a prescription-only medicine.

A safer approach is to make sure that:

A legitimate healthcare professional assesses you The medicine is prescribed appropriately The medicine comes from a legitimate pharmacy supply chain You receive instructions about how to use it You know who to contact if you experience problems You have appropriate follow-up

Avoid sellers offering prescription weight loss injections through social media, messaging platforms or websites that do not require proper medical assessment.

What Are the Common Side Effects?

Weight management medicines can cause side effects, and the risks vary depending on the medicine and individual circumstances.

Gastrointestinal effects such as:

Nausea Vomiting Diarrhoea Constipation Abdominal discomfort

can occur with GLP-1 or related medicines.

MHRA advises people using these medicines to follow the prescribed dosing schedule and not increase the dose themselves in an attempt to accelerate weight loss.

More serious adverse effects can also occur, so treatment should be discussed with a healthcare professional.

Certain medicines may also be unsuitable during pregnancy, breastfeeding or in people with particular medical conditions. NHS England specifically advises that tirzepatide is not recommended in pregnancy or breastfeeding and that certain health conditions can affect suitability.

Why Lifestyle Support Is Part of Treatment

Weight loss injections are not designed to replace healthy eating or physical activity.

NICE recommends weight management medicines alongside a reduced-calorie diet and increased physical activity.

NHS specialist services can also provide support from different healthcare professionals, such as dietitians and psychologists.

This matters because successful weight management is not simply about taking a medicine for a short period. Treatment decisions may involve monitoring, lifestyle changes, response to treatment and longer-term planning.

What Should You Check Before Starting Treatment?

Before starting an NHS or private weight management medicine, consider asking:

Am I actually eligible?

BMI is only one part of the assessment.

Which medicine is being considered?

Wegovy and Mounjaro have different active ingredients and treatment pathways.

What happens after the initial prescription?

Ask how follow-up appointments and monitoring work.

What side effects should I watch for?

Make sure you understand when to contact your healthcare provider.

What happens if the medicine does not work well enough?

NICE guidance includes treatment-review criteria for some medicines, so ongoing treatment should be reassessed rather than assumed to continue indefinitely.

How much will private treatment actually cost?

Look beyond the headline price and check whether consultation, medication, follow-up and prescription fees are included.

Frequently Asked Questions Can I get weight loss injections on the NHS?

Some people can receive weight management injections through the NHS if they meet the relevant clinical criteria and are able to access the appropriate NHS pathway.

Eligibility depends on the medicine, BMI, weight-related health conditions and local service arrangements.

What BMI qualifies for weight loss injections on the NHS?

There is no single BMI threshold covering every medicine and every patient.

For example, NICE recommends semaglutide and tirzepatide for specific groups with obesity and weight-related health conditions, generally using a BMI threshold of 35 kg/m², with lower thresholds in certain circumstances.

Can I get Wegovy on the NHS?

Wegovy may be available through a specialist weight management service if you meet the relevant NICE and local NHS criteria.

Can I get Mounjaro on the NHS?

Mounjaro is available through NHS weight management pathways for eligible patients. NHS England is implementing access in phases, with the initial primary-care rollout prioritising people with the highest clinical need.

How much does Wegovy cost on the NHS?

Eligible patients in England generally pay the standard NHS prescription charge if they are not exempt. The current charge is £9.90 per prescription item.

How much does Mounjaro cost privately?

Private prices vary by provider, dose, consultation and whether follow-up services are included. A private price should not be confused with the NHS prescription charge or the medicine's NHS commercial price.

Are online weight loss injections safe?

Only use prescription medicines supplied through legitimate healthcare and pharmacy channels. MHRA warns against buying weight-loss medicines from unregulated websites and social media because counterfeit or incorrectly dosed products can pose serious risks.

Do weight loss injections work without lifestyle changes?

NICE recommends weight management medicines alongside a reduced-calorie diet and increased physical activity rather than treating them as a standalone solution.

Final Thoughts

NHS weight loss injections in 2026 are becoming an increasingly important part of medical weight management, but access is based on clinical criteria rather than simply requesting a prescription.

Wegovy and Mounjaro are important medicines within the current NHS weight management landscape, but their eligibility requirements and access pathways are not identical.

For anyone searching for NHS weight loss injections, Wegovy NHS eligibility, Mounjaro NHS eligibility, BMI requirements, NHS weight loss injection costs or private alternatives, the most important step is to distinguish between national guidance and the local pathway actually available to you.

In England, NHS England and NICE provide the most useful starting points for understanding eligibility and treatment pathways. Private treatment can be an alternative for some people, but it should still involve proper clinical assessment and legitimate medicine supply.

Above all, avoid unregulated sellers and social-media offers promising fast or guaranteed weight loss. MHRA continues to warn that illegally supplied weight-loss medicines can pose serious health risks.